大灣區聚變力量(01189.HK):譚頌燊及何則文獲委任爲公司附屬瀋陽酒店董事
格隆匯9月4日丨大灣區聚變力量(01189.HK)公告,董事會宣佈及確認(i)譚頌燊及何則文已獲委任爲公司的附屬公司沈陽酒店股份有限公司的董事,自2023年4月17日起生效;(ii)劉美宣已獲委任爲沈陽酒店的董事,自2025年1月2日起生效,以處理沈陽酒店及公司於中華人民共和國註冊成立的附屬公司沈陽珀麗酒店有限公司的公司事務;及(iii)樑家駿自2024年10月20日起不再擔任沈陽酒店的董事。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.